β¨ Education and Health Notices
4088 NEW ZEALAND GAZETTE, No. 156 9 OCTOBER 2008
of Education on behalf of Her Majesty The Queen, acting through the Group Manager, Regional Education, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
Rudolf Steiner School, Dunedin.
The said supplementary integration agreement was executed on 30 September 2008.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the local office of the Ministry of Education, 414 Moray Place, Hamilton.
Dated at Wellington this 30th day of September 2008.
JIM GREENING, Senior Manager, Schools and Student Support.
go7517
Education Review Office
Public Finance Act 1989
Notice of Publication of Annual ReportβEducation Review Office
Pursuant to section 44 of the Public Finance Act 1989, I hereby give notice that the Education Review Office has published its annual report for the year ending 30 June 2008, containing its financial statements, audit report and statement of responsibility for the period.
HON CHRIS CARTER, Minister Responsible for the Education Review Office.
go7530
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Pravastatin
Active Ingredient: Pravastatin sodium 10mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Etobicoke, Ontario, Canada
Product: Apo-Pravastatin
Active Ingredient: Pravastatin sodium 20mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Etobicoke, Ontario, Canada
Product: Apo-Pravastatin
Active Ingredient: Pravastatin sodium 40mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Etobicoke, Ontario, Canada
Product: Apo-Risperidone
Active Ingredient: Risperidone 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Richmond Hill, Ontario, Canada
Product: Asamax 500
Active Ingredient: Mesalazine 500mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: CSL Biotherapies (NZ) Limited
Manufacturer: QPharma AB, Malmo, Sweden
Product: Exforge
Active Ingredients: Amlodipine besilate 13.87mg equivalent to amlodipine 10mg
Valsartan 160mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Next Page →
β¨ LLM interpretation of page content
π Supplementary Integration Agreement for Rudolf Steiner School
π Education, Culture & Science30 September 2008
Integration Agreement, Rudolf Steiner School, Dunedin, Ministry of Education
- Jim Greening, Senior Manager, Schools and Student Support
π Publication of Annual Report for Education Review Office
π Education, Culture & ScienceAnnual Report, Education Review Office, Public Finance Act 1989
- Hon Chris Carter, Minister Responsible for the Education Review Office
π₯ Consent to Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Distribution, Medicines Act 1981, New Medicines
- Minister of Health
NZ Gazette 2008, No 156